Berberine inhibits the development of endometrial cancer through circ_ZNF608/miR-377-3p/COX2 axis. (30th September 2022)
- Record Type:
- Journal Article
- Title:
- Berberine inhibits the development of endometrial cancer through circ_ZNF608/miR-377-3p/COX2 axis. (30th September 2022)
- Main Title:
- Berberine inhibits the development of endometrial cancer through circ_ZNF608/miR-377-3p/COX2 axis
- Authors:
- Liang, Huan
Liu, Yi
Fu, Lian
Li, Ling
Gong, Nianjin - Abstract:
- Abstract: Objective: Endometrial carcinoma (EC) is a common malignant tumour in women. Berberin (BBR) is an alkaloid with anti-tumour activity, and circular RNA (circRNAs) has been extensively studied in cancers. However, whether BBR regulates the development of EC by regulating circular RNA zinc finger protein 608 (ZNF608) is unknown. Methods: Different concentrations of BBR were used to treat endometrial cancer cells. A quantitative real-time polymerase chain reaction (qRT-PCR) was conducted to assess the expression of circ_ZNF608, microRNA-377-3p (miR-377-3p) and cyclooxygenase 2 (COX2). The expression of COX2 protein was detected by western blot. The effect of circ_ZNF608 in BBR-treated EC cells was verified by 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) assay, thymidine analog 5-ethynyl-2'-deoxyuridine (EdU) assay, colony formation assay, transwell, and flow cytometry. The effect of BBR and circ_ZNF608 on tumour growth was evaluated by xenograft tumour model in vivo . Results: Berberine can inhibit the proliferation and metastasis of EC cells and promote apoptosis, which is related to the concentration. Circ_ZNF608 and COX2 were abnormally increased, while the levels of miR-377-3p were reversed in EC tissues and cells. Overexpression of circ_ZNF608 can restore the inhibitory effect of BBR on EC cells. In addition, circ_ZNF608 restored the inhibitory effect of BBR on EC cells by inhibiting the expression of miR-377-3p. Similarly, MiR-377-3p/COX2Abstract: Objective: Endometrial carcinoma (EC) is a common malignant tumour in women. Berberin (BBR) is an alkaloid with anti-tumour activity, and circular RNA (circRNAs) has been extensively studied in cancers. However, whether BBR regulates the development of EC by regulating circular RNA zinc finger protein 608 (ZNF608) is unknown. Methods: Different concentrations of BBR were used to treat endometrial cancer cells. A quantitative real-time polymerase chain reaction (qRT-PCR) was conducted to assess the expression of circ_ZNF608, microRNA-377-3p (miR-377-3p) and cyclooxygenase 2 (COX2). The expression of COX2 protein was detected by western blot. The effect of circ_ZNF608 in BBR-treated EC cells was verified by 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) assay, thymidine analog 5-ethynyl-2'-deoxyuridine (EdU) assay, colony formation assay, transwell, and flow cytometry. The effect of BBR and circ_ZNF608 on tumour growth was evaluated by xenograft tumour model in vivo . Results: Berberine can inhibit the proliferation and metastasis of EC cells and promote apoptosis, which is related to the concentration. Circ_ZNF608 and COX2 were abnormally increased, while the levels of miR-377-3p were reversed in EC tissues and cells. Overexpression of circ_ZNF608 can restore the inhibitory effect of BBR on EC cells. In addition, circ_ZNF608 restored the inhibitory effect of BBR on EC cells by inhibiting the expression of miR-377-3p. Similarly, MiR-377-3p/COX2 can regulate the tumour progression of EC under BBR. Finally, BBR can inhibit the growth of endometrial carcinoma in vivo . Conclusion: BBR was found to inhibit EC via the circ_ZNF608/miR-377-3p/COX2 axis, which is helpful in endometrial carcinoma. … (more)
- Is Part Of:
- Autoimmunity. Volume 55:Number 7(2022)
- Journal:
- Autoimmunity
- Issue:
- Volume 55:Number 7(2022)
- Issue Display:
- Volume 55, Issue 7 (2022)
- Year:
- 2022
- Volume:
- 55
- Issue:
- 7
- Issue Sort Value:
- 2022-0055-0007-0000
- Page Start:
- 485
- Page End:
- 495
- Publication Date:
- 2022-09-30
- Subjects:
- Circ_ZNF608 -- miR-377-3p -- COX2 -- endometrial carcinoma -- berberine
Autoimmunity -- Periodicals
Autoimmune diseases -- Periodicals
571.973 - Journal URLs:
- http://informahealthcare.com/journal/aut ↗
http://informahealthcare.com ↗
http://www.gbhap.com/journals/350/350-top.htm ↗ - DOI:
- 10.1080/08916934.2021.2010050 ↗
- Languages:
- English
- ISSNs:
- 0891-6934
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 1828.345000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 24038.xml